Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients

World Journal of Gastroenterology

Volumn 15, Issue 10, 2009, Pages 1237-1241

  Pérez Rodríguez, Ma Teresa ^a   Sopeña, Bernardo ^a,c   Crespo, Manuel ^b   Rivera, Alberto ^a   del Blanco, Teresa González ^a   Ocampo, Antonio ^a   Martínez Vázquez, César ^c  

^a HOSPITAL XERAL CÍES   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

"Anti HBc alone"; Hepatitis B virus DNA; Human immunodeficiency virus; Liver disease; Occult hepatitis

Indexed keywords

CD4 ANTIGEN; HEPATITIS B CORE ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; SEROLOGY; VIRUS REPLICATION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; LIVER FUNCTION TEST; MIDDLE AGED; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HIV; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 65649121470     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1237     Document Type: Article

References (24)

1. Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002; 36: 681-686
2. Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA. Frequentoccult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003; 22: 92-98
3. Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004; 36: 869-875
4. Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006; 44: S65-S70
5. Levy V, Grant RM. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin Infect Dis 2006; 43: 904-910
6. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med 2007; 356: 1445-1454
7. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62: 450-455
8. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194-203
9. Hofer M, Joller-Jemelka HI, Grob PJ, Lüthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17: 6-13
10. Colomina-Rodríguez J, González-García D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection.] Enferm Infecc Microbiol Clin 2005; 23: 80-85
11. Neau D, Winnock M, Jouvencel AC, Faure M, Castera L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005; 40: 750-753
12. Núñez M, Ríos P, Pérez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002; 16: 2099-1101
13. Pogány K, Zaaijer HL, Prins JM, Wit FW, Lange JM, Beld MG. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients. AIDS Res Hum Retroviruses 2005; 21: 922-926
14. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851
15. Wagner AA, Loustaud-Ratti V, Chemin I, Weinbreck P, Denis F, Alain S. Double hepatitis B virus infection in a patient with HIV/hepatitis C virus coinfection and 'anti-HBc alone' as serological pattern. Eur J Clin Microbiol Infect Dis 2005; 24: 623-627
16. Knöll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J Gastroenterol 2006; 12: 1255-1260
17. Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 2004; 5: 171-173
18. Wedemeyer H, Cornberg M, Tegtmeyer B, Frank H, Tillmann HL, Manns MP. Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. Clin Microbiol Infect 2004; 10: 70-72
19. Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 2003; 36: 1602-1605
20. Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007; 45: 736-740
21. Gonçales FL Jr, Pereira JS, Da Silva C, Thomaz GR, Pavan MH, Fais VC, Magna LA, Gonçales NS. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus. Clin Diagn Lab Immunol 2003; 10: 718-720
22. Gaglio PJ, Sterling R, Daniels E, Tedaldi E. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. Clin Infect Dis 2007; 45: 618-623
23. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006; 4: 936-962
24. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology 2004; 39: 857-861